p53 expression and disease outcome of breast cancer patients undergoing primary chemotherapy with anthracycline-containing regimens

被引：1
|
作者：
Bottini, A [1 ]
Dogliotti, L
Bersiga, A
Brizzi, MP
Berruti, A
机构：
[1] Azienda Osped Ist Ospitalieri, Breast Unit, Cremona, Italy
[2] Azienda Osped San Luigi Orbassano, San Luigi Orbassano, Italy
来源：
ANNALS OF ONCOLOGY | 2003年 / 14卷 / 07期
关键词：
D O I：
10.1093/annonc/mdg298
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1156 / 1156
页数：1
相关论文
共 50 条
  • [1] Adjuvant Chemotherapy in Early Breast Cancer: Optimal and Suboptimal Anthracycline-Containing Regimens
    Giorgio Cocconi
    Breast Cancer Research and Treatment, 2003, 80 : 313 - 320
  • [2] Adjuvant chemotherapy in early breast cancer: optimal and suboptimal anthracycline-containing regimens
    Cocconi, G
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (03) : 313 - 320
  • [3] p53 Expression in Pretreatment Specimen Predicts Response to Neoadjuvant Chemotherapy Including Anthracycline and Taxane in Patients with Primary Breast Cancer
    Shien, Tadahiko
    Kinoshita, Takayuki
    Seki, Kunihiko
    Yoshida, Miwa
    Hojo, Takashi
    Shimizu, Chikako
    Taira, Naruto
    Doihara, Hiroyoshi
    Akashi-Tanaka, Sadako
    Tsuda, Hitoshi
    Fujiwara, Yasuhiro
    ACTA MEDICA OKAYAMA, 2013, 67 (03) : 165 - 170
  • [4] Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy
    Kan Yonemori
    Noriyuki Katsumata
    Masayuki Kaneko
    Hajime Uno
    Koji Matsumoto
    Tsutomu Kouno
    Chikako Shimizu
    Masashi Ando
    Masahiro Takeuchi
    Yasuhiro Fujiwara
    Breast Cancer Research and Treatment, 2007, 103 : 313 - 318
  • [5] Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy
    Yonemori, Kan
    Katsumata, Noriyuki
    Kaneko, Masayuki
    Uno, Hajime
    Matsumoto, Koji
    Kouno, Tsutomu
    Shimizu, Chikako
    Ando, Masashi
    Takeuchi, Masahiro
    Fujiwara, Yasuhiro
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (03) : 313 - 318
  • [6] Changes in the Expression Landscape of HER2-Negative Breast Cancer under the Influence of Anthracycline-Containing Neoadjuvant Chemotherapy Regimens
    Ibragimova, M. K.
    Tsyganov, M. M.
    Kravtsova, E. A.
    Litviakov, N. V.
    BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY, 2024, 18 (04) : 368 - 382
  • [7] Activity of gemcitabine in metastatic breast cancer (MBC) patients previously treated with anthracycline-containing regimens
    Spielmann, M
    Kalla, S
    LlombartCussac, A
    Espie, M
    Namer, M
    Ferrero, JM
    Cuvier, C
    Fumoleau, P
    Ponzio, A
    Kayitalire, L
    Pouillart, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 663 - 663
  • [8] Toxicity and tolerability of the anthracycline-containing regimen in adjuvant chemotherapy for breast cancer
    Jagiello-Gruszfeld, A.
    Lowczak, A.
    Zbrzezniak-Smilgiewicz, J.
    Szablowska-Siwik, S.
    Licznerska, G.
    BREAST, 2007, 16 : S42 - S42
  • [9] Topoisomerase IIα Expression and Amplification of Breast cancer - Affects the Effectiveness of adjuvant Anthracycline-containing Chemotherapy?
    Schindlbeck, C.
    Mayr, D.
    Olivier, C.
    Jeschke, U.
    Rack, B.
    Sommer, H.
    Friese, K.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (08) : 759 - 759
  • [10] Pegfilgrastim promotes neutrophil recovery in elderly breast cancer patients following anthracycline-containing chemotherapy
    Brugger, W.
    Bacon, P.
    Lawrinson, S.
    Romieu, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S72 - S72
12345